The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/69239 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Tanisha D Belton and 16 co-authors. Institution: PolicyLab, Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States. Major MEDLINE topics: Anemia, Sickle Cell, Community Health Workers, Transition to Adult Care. 70 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Transitioning from pediatric to adult sickle cell disease (SCD) care is challenging for emerging adults (aged 17-25 years). This period is marked by a 7-fold increase in mortality rates and has the highest rates of hospitalizations, emergency room visits, and hospital readmissions compared with children living with SCD. These challenges are exacerbated by fragmented care coordination, difficulty navigating adult health care systems, and increased self-management responsibilities.
Objective
This study aims to compare the effectiveness of 2 interventions designed to support emerging adults living with SCD during this transition: a mobile health (mHealth) app and community health worker (CHW) support to standard care.
Methods
The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) trial is an ongoing multicenter, 3-arm, open-label randomized controlled trial; 375 emerging adults (aged 17-25 years) are being enrolled and randomized 1:1:1 to (1) a 6-month CHW intervention focused on self-management skills, symptom tracking, care coordination, and transition planning; (2) a 6-month mHealth self-management program (enhanced iManage application) with tailored SMS text messaging (THRIVE [Texting Health-Related Resources to Inform, Motivate, and Engage] 2.0); or (3) enhanced usual care (control). Participants are followed for 18 months. The primary outcome is the change in self-reported health-related quality of life assessed using the PedsQL SCD module. Secondary outcomes include acute care use (hospitalizations and emergency department visits), patient activation, self-management behavior, and successful transfer to adult hematology care.
Results
The institutional review board at Children’s Hospital of Philadelphia approved this study in June 2018. Recruitment began in January 2019 and ended in December 2022; we completed data collection in November 2024. We have enrolled a total of 405 participants.
Conclusions
This trial addresses a critical gap in transition intervention research for young adults with SCD. It will provide evidence on the comparative effectiveness of 2 promising interventions (CHW and mHealth) and inform the development of scalable and sustainable transition support programs. Findings will have implications for improving health-related quality of life, reducing acute care use, and promoting successful transition to adult-centered SCD care for this vulnerable population. Trial Registration ClinicalTrials.gov NCT03648710; https://clinicaltrials.gov/study/NCT03648710 International Registered Report Identifier (IRRID) DERR1-10.2196/69239
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- PolicyLab, Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
- Department of Pediatrics, Northwell Health, New Hyde Park, NY, United States.
- Department of Pediatrics, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
- Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
- Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.
- Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
ORCID profiles: Tanisha D Belton, Caren M Steinway, Olivia Teng, Justine Shults, Lamia P Barakat, Banu Aygun, Abena Appiah-Kubi, Lori E Crosby, Omar Niss, Biree Andemariam, Lisa A Schwartz, Samantha Luma, Kyle A Smith, Tracey B Johnson, David M Rubin, Kim M Smith-Whitley, Sophia Jan
Cite
APA
Belton, T. D., Steinway, C. M., Teng, O., Shults, J., Barakat, L. P., Aygun, B., Appiah-Kubi, A., Crosby, L. E., Niss, O., Andemariam, B., Schwartz, L. A., Luma, S., Smith, K. A., Johnson, T. B., Rubin, D. M., Smith-Whitley, K. M., & Jan, S. (2025). The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/69239
Vancouver
Belton TD, Steinway CM, Teng O, Shults J, Barakat LP, Aygun B, et al. The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/69239
BibTeX
@article{Belton2025,
author = {Belton, Tanisha D and Steinway, Caren M and Teng, Olivia and Shults, Justine and Barakat, Lamia P and Aygun, Banu and Appiah-Kubi, Abena and Crosby, Lori E and Niss, Omar and Andemariam, Biree and Schwartz, Lisa A and Luma, Samantha and Smith, Kyle A and Johnson, Tracey B and Rubin, David M and Smith-Whitley, Kim M and Jan, Sophia},
title = {The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/69239}
}
EUVIMED